• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CDA
Click for more information
2.88% $15.86

CODAN LIMITED - Charts / Financials

Market Cap $2.879B  ! watchlist Created with Sketch. Add to my watchlist
Technology Scientific & Technical Instruments

Codan Limited is an Australia-based technology company. The Company develops robust... Codan Limited is an Australia-based technology company. The Company develops robust technology solutions to solve customers’ communications, safety, security and productivity problems. It develops rugged and reliable electronics solutions for government, corporate, NGO and consumer markets across the globe. The Company’s segments include Communications, Metal Detection and Others. The Communications segment includes the design, development, manufacture, and marketing of communication solutions. The Metal Detection segment includes the design, development, manufacture, and marketing of metal detection equipment. The Other business segment relates to the manufacturing and sale of tracking products to Caterpillar Inc. Its metal detection business includes Minelab. Its Communications business includes Domo Tactical Communications and Zetron. The Company’s products are sold in more than 150 countries with a global network of dealers, distributors and agents.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 02/10/2024 (20 minute delay) ?
Day
Open $16.21   Day High $16.33   Day Low $15.83
Daily Volume 343029
Bids   Sellers
Number Price Volume   Number Price Volume
1 $15.82 2000   1 $15.89 130

Directors & Senior Management

Mr. Alfonzo Ianniello Chief Executive Officer, Managing Director, Executive Director
Mr. Michael Barton Chief Financial Officer, Company Secretary
Ms. Marjolijn Woods Chief Human Resource Officer
Mr. Scott French President and Executive General Manager of Zetron
Mr. Ben Harvey President and Executive General Manager - Minelab
Mr. Daniel Hutchinson Executive General Manager Strategy, Corporate Development and M&A
Mr. Paul Sangster President and Executive General Manager - Tactical Communications
Mr. Daniel Widera Joint Company Secretary
Mr. Graeme R. C. Barclay Independent Non-Executive Chairman of the Board
Ms. Sarah Elizabeth Adam-Gedge Non-Executive Independent Director
Ms. Kathryn Joy Gramp Non-Executive Independent Director
Mr. Heith Mackay-Cruise Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$15.86 		Change
-0.470(2.88%) 		Mkt cap ! $2.879B
Open High Low Value Volume
$16.21 $16.33 $15.83 $5.484M 343.0K

Buyers (Bids)

No. Vol. Price($)
1 2000 $15.82
 

Sellers (Offers)

Price($) Vol. No.
$15.89 130 1
View Market Depth
Last trade - 16.10pm 02/10/2024 (20 minute delay) ?
Last
$15.92 		  Change
-0.470 ( 2.68 %)
Open High Low Volume
$16.28 $16.31 $15.84 70451
Last updated 15.59pm 02/10/2024 ?

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
SPC to merge with Original Juice Co and Nature One Dairy The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.